- Home
- CPHC vs SRZN Comparison
CPHC vs SRZN Comparison
Compare CPHC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHC
- SRZN
- Stock Information
- Founded
- CPHC 1994
- SRZN 2015
- Country
- CPHC United States
- SRZN United States
- Employees
- CPHC N/A
- SRZN N/A
- Industry
- CPHC Services-Misc. Amusement & Recreation
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- CPHC Consumer Discretionary
- SRZN Health Care
- Exchange
- CPHC Nasdaq
- SRZN Nasdaq
- Market Cap
- CPHC 92.5M
- SRZN 97.3M
- IPO Year
- CPHC 1994
- SRZN N/A
- Fundamental
- Price
- CPHC $16.43
- SRZN $11.45
- Analyst Decision
- CPHC
- SRZN Strong Buy
- Analyst Count
- CPHC 0
- SRZN 2
- Target Price
- CPHC N/A
- SRZN $38.50
- AVG Volume (30 Days)
- CPHC 2.3K
- SRZN 12.2K
- Earning Date
- CPHC 11-06-2025
- SRZN 11-05-2025
- Dividend Yield
- CPHC 1.70%
- SRZN N/A
- EPS Growth
- CPHC N/A
- SRZN N/A
- EPS
- CPHC 0.03
- SRZN N/A
- Revenue
- CPHC $60,069,270.00
- SRZN $12,621,000.00
- Revenue This Year
- CPHC N/A
- SRZN N/A
- Revenue Next Year
- CPHC N/A
- SRZN N/A
- P/E Ratio
- CPHC $557.89
- SRZN N/A
- Revenue Growth
- CPHC N/A
- SRZN N/A
- 52 Week Low
- CPHC $16.15
- SRZN $5.90
- 52 Week High
- CPHC $22.93
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- CPHC 38.78
- SRZN 52.78
- Support Level
- CPHC $16.40
- SRZN $11.36
- Resistance Level
- CPHC $16.87
- SRZN $12.11
- Average True Range (ATR)
- CPHC 0.27
- SRZN 0.69
- MACD
- CPHC 0.05
- SRZN -0.13
- Stochastic Oscillator
- CPHC 2.88
- SRZN 27.07
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).